Magnetic resonance elastography of the liver

Sumeet K. Asrani, Jayant A. Talwalkar

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Elastography evaluates the intrinsic mechanical viscoelastic properties of liver parenchyma and allow for estimation of liver stiffness (LS), whereby elevated stiffness is associated with presence of advanced fibrosis. Measurement of liver stiffness by magnetic resonance elastography (MRE) has been tested for staging of liver disease in a variety of patients, providing convincing data especially among those with non-alcoholic fatty liver disease. Beyond diagnosis, non-invasive measures may have a prognostic role. Measurement of LS by MRE may serve as a complementary tool to monitor progression of disease. However, clinical algorithms are needed whereby MRE and other non-invasive markers can seamlessly be incorporated in care of patients with CLD, keeping in mind the cost, accessibility and incremental clinical utility offered above and beyond that which may be gained by simple bedside clinical assessment.

Original languageEnglish (US)
Title of host publicationDiagnostic Methods for Cirrhosis and Portal Hypertension
PublisherSpringer International Publishing
Pages225-238
Number of pages14
ISBN (Electronic)9783319726281
ISBN (Print)9783319726274
DOIs
StatePublished - Jan 1 2018

Fingerprint

Elasticity Imaging Techniques
Magnetic resonance
Liver
Stiffness
Disease Progression
Liver Diseases
Patient Care
Fibrosis
Costs and Cost Analysis
Mechanical properties
Costs

Keywords

  • Cirrhosis
  • Compensated
  • Decompensated
  • Magnetic resonance elastography
  • Portal hypertension
  • Prognosis
  • Serum tests
  • Transient elastography

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Asrani, S. K., & Talwalkar, J. A. (2018). Magnetic resonance elastography of the liver. In Diagnostic Methods for Cirrhosis and Portal Hypertension (pp. 225-238). Springer International Publishing. https://doi.org/10.1007/978-3-319-72628-1_15

Magnetic resonance elastography of the liver. / Asrani, Sumeet K.; Talwalkar, Jayant A.

Diagnostic Methods for Cirrhosis and Portal Hypertension. Springer International Publishing, 2018. p. 225-238.

Research output: Chapter in Book/Report/Conference proceedingChapter

Asrani, SK & Talwalkar, JA 2018, Magnetic resonance elastography of the liver. in Diagnostic Methods for Cirrhosis and Portal Hypertension. Springer International Publishing, pp. 225-238. https://doi.org/10.1007/978-3-319-72628-1_15
Asrani SK, Talwalkar JA. Magnetic resonance elastography of the liver. In Diagnostic Methods for Cirrhosis and Portal Hypertension. Springer International Publishing. 2018. p. 225-238 https://doi.org/10.1007/978-3-319-72628-1_15
Asrani, Sumeet K. ; Talwalkar, Jayant A. / Magnetic resonance elastography of the liver. Diagnostic Methods for Cirrhosis and Portal Hypertension. Springer International Publishing, 2018. pp. 225-238
@inbook{3c801e337f0b4c7e9d0130bc7b95bfa2,
title = "Magnetic resonance elastography of the liver",
abstract = "Elastography evaluates the intrinsic mechanical viscoelastic properties of liver parenchyma and allow for estimation of liver stiffness (LS), whereby elevated stiffness is associated with presence of advanced fibrosis. Measurement of liver stiffness by magnetic resonance elastography (MRE) has been tested for staging of liver disease in a variety of patients, providing convincing data especially among those with non-alcoholic fatty liver disease. Beyond diagnosis, non-invasive measures may have a prognostic role. Measurement of LS by MRE may serve as a complementary tool to monitor progression of disease. However, clinical algorithms are needed whereby MRE and other non-invasive markers can seamlessly be incorporated in care of patients with CLD, keeping in mind the cost, accessibility and incremental clinical utility offered above and beyond that which may be gained by simple bedside clinical assessment.",
keywords = "Cirrhosis, Compensated, Decompensated, Magnetic resonance elastography, Portal hypertension, Prognosis, Serum tests, Transient elastography",
author = "Asrani, {Sumeet K.} and Talwalkar, {Jayant A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-72628-1_15",
language = "English (US)",
isbn = "9783319726274",
pages = "225--238",
booktitle = "Diagnostic Methods for Cirrhosis and Portal Hypertension",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Magnetic resonance elastography of the liver

AU - Asrani, Sumeet K.

AU - Talwalkar, Jayant A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Elastography evaluates the intrinsic mechanical viscoelastic properties of liver parenchyma and allow for estimation of liver stiffness (LS), whereby elevated stiffness is associated with presence of advanced fibrosis. Measurement of liver stiffness by magnetic resonance elastography (MRE) has been tested for staging of liver disease in a variety of patients, providing convincing data especially among those with non-alcoholic fatty liver disease. Beyond diagnosis, non-invasive measures may have a prognostic role. Measurement of LS by MRE may serve as a complementary tool to monitor progression of disease. However, clinical algorithms are needed whereby MRE and other non-invasive markers can seamlessly be incorporated in care of patients with CLD, keeping in mind the cost, accessibility and incremental clinical utility offered above and beyond that which may be gained by simple bedside clinical assessment.

AB - Elastography evaluates the intrinsic mechanical viscoelastic properties of liver parenchyma and allow for estimation of liver stiffness (LS), whereby elevated stiffness is associated with presence of advanced fibrosis. Measurement of liver stiffness by magnetic resonance elastography (MRE) has been tested for staging of liver disease in a variety of patients, providing convincing data especially among those with non-alcoholic fatty liver disease. Beyond diagnosis, non-invasive measures may have a prognostic role. Measurement of LS by MRE may serve as a complementary tool to monitor progression of disease. However, clinical algorithms are needed whereby MRE and other non-invasive markers can seamlessly be incorporated in care of patients with CLD, keeping in mind the cost, accessibility and incremental clinical utility offered above and beyond that which may be gained by simple bedside clinical assessment.

KW - Cirrhosis

KW - Compensated

KW - Decompensated

KW - Magnetic resonance elastography

KW - Portal hypertension

KW - Prognosis

KW - Serum tests

KW - Transient elastography

UR - http://www.scopus.com/inward/record.url?scp=85046930174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046930174&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-72628-1_15

DO - 10.1007/978-3-319-72628-1_15

M3 - Chapter

SN - 9783319726274

SP - 225

EP - 238

BT - Diagnostic Methods for Cirrhosis and Portal Hypertension

PB - Springer International Publishing

ER -